Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05937373 · ClinicalTrials.gov registry record · NA
Perioperative Continuous Glucose Monitoring
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT05937373 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 22 participants.
The verdict
NCT05937373, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
To evaluate use of continuous glucose monitoring (CGM) technology in the preoperative setting: evaluate feasibility of placement of CGM during preoperative clinic visit with intent to utilize CGM throughout perioperative period.
Interventions
- OTHER Standard of Care
- DEVICE Continuous Glucose monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2023-08-04 |
| Est. Completion | 2024-05-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05937373
The ClinicalTrials.gov registry entry for NCT05937373 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT05937373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05937373 about?
NCT05937373 is a clinical study titled "Perioperative Continuous Glucose Monitoring". To evaluate use of continuous glucose monitoring (CGM) technology in the preoperative setting: evaluate feasibility of placement of CGM during preoperative clinic visit with intent to utilize CGM throughout perioperative period.
What is the current status of trial NCT05937373?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2023-08-04. Estimated completion is 2024-05-21.
What interventions are being tested in trial NCT05937373?
The interventions under investigation include: Standard of Care (OTHER), Continuous Glucose monitor (DEVICE).
Who is sponsoring clinical trial NCT05937373?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.